Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations
about
Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposalShiga Toxin (Stx) Classification, Structure, and FunctionUtility of Whole-Genome Sequencing of Escherichia coli O157 for Outbreak Detection and Epidemiological SurveillanceFirst step in using molecular data for microbial food safety risk assessment; hazard identification of Escherichia coli O157:H7 by coupling genomic data with in vitro adherence to human epithelial cells.A process for analysis of microarray comparative genomics hybridisation studies for bacterial genomesOutbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausagesIsolation and genetic characterization of a coinfection of non-O157 Shiga toxin-producing Escherichia coliVariation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaksIncreased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathwaysShiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease.Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains.A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in ChinaA novel murine infection model for Shiga toxin-producing Escherichia coli.Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care centerHemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coliComparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.Hybrids of Shigatoxigenic and Enterotoxigenic Escherichia coli (STEC/ETEC) Among Human and Animal Isolates in Finland.Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phagesGenomic Comparison of Two O111:H- Enterohemorrhagic Escherichia coli Isolates from a Historic Hemolytic-Uremic Syndrome Outbreak in Australia.Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.Verotoxigenic Escherichia coli O157:H7 from Swedish cattle; isolates from prevalence studies versus strains linked to human infections--a retrospective study.A qPCR assay to detect and quantify Shiga toxin-producing E. coli (STEC) in cattle and on farms: a potential predictive tool for STEC culture-positive farms.Emerging types of Shiga toxin-producing E. coli (STEC) O178 present in cattle, deer, and humans from Argentina and Germany.Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1.Genetic diversity and virulence potential of shiga toxin-producing Escherichia coli O113:H21 strains isolated from clinical, environmental, and food sources.Spread of a distinct Stx2-encoding phage prototype among Escherichia coli O104:H4 strains from outbreaks in Germany, Norway, and Georgia.Carriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157.Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.Shiga toxin subtypes display dramatic differences in potencyPhylogenetic Clades 6 and 8 of Enterohemorrhagic Escherichia coli O157:H7 With Particular stx Subtypes are More Frequently Found in Isolates From Hemolytic Uremic Syndrome Patients Than From Asymptomatic Carriers.Predicting the public health benefit of vaccinating cattle against Escherichia coli O157A polyclonal antibody based immunoassay detects seven subtypes of Shiga toxin 2 produced by Escherichia coli in human and environmental samples.PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 yearsCo-detection of virulent Escherichia coli genes in surface water sourcesInsight into Shiga toxin genes encoded by Escherichia coli O157 from whole genome sequencingCharacterization of enteropathogenic and Shiga toxin-producing Escherichia coli in cattle and deer in a shared agroecosystem.
P2860
Q26827657-42509856-5959-4BD9-8350-8E554ECB7FBAQ27021676-031953F1-84C6-460D-8D61-5E7A0C9EA294Q28610949-0F7966A6-7B04-465E-8412-4EE0005051F3Q30939362-BD1E40A8-3752-4EF0-AE38-E1FF33AE2AF0Q33317061-62B7B1B1-5EDA-4912-BEEA-FB8B82B0FA6AQ33326889-62077E68-58F3-4D81-AFAB-B3EFBEE0D775Q33376522-0B2888A3-703E-49F2-819C-9A66B1C1B489Q33378926-95116964-ACC9-4472-BE53-8D3850AA8D67Q33389308-2FC6E427-FEDC-4BC9-8446-5947740D4D7EQ33396539-A1F858F4-3781-44B4-A694-5B1143B4C7F7Q33396843-A57C5B61-FCA8-4034-BFA4-E923C7CD9C72Q33399393-48ABC6FB-5D5B-4B10-91E3-92B3EB897E2BQ33401064-5796ED4E-71A8-474E-98A5-A65FD52BC6D6Q33403695-35761F5A-DB29-402B-A3A2-327DF3B1F53EQ33403700-047354BB-60AD-4EEF-984A-3195E3EB22CEQ33404523-F1183CF0-8375-45D2-B395-245E18AB701CQ33413183-D376D2AE-40EB-417B-A59C-C1A13544DB92Q33418482-87EE4A39-2B11-4C74-AF73-81092187AE40Q33419670-12EF884D-DB4B-4723-A7AA-2DEE55230875Q33425076-39E0FA1A-E097-4B57-BDF5-38FD48590841Q33426304-CA29C6AD-DD91-47EB-B107-3B7A57CF26E1Q33428897-89B0FF9A-CC00-417E-9FCB-F423BDDEC2E3Q33429632-84C9774B-1F46-4DE7-8C47-6DA6E4D3F582Q33527565-972A4BDD-2D27-4552-A751-3B181D16C6E3Q33584828-56384638-174E-49B1-8CEF-BCCD30CF9788Q33764839-FD8920A7-E64A-45BE-9516-C1AC25DA7D9AQ33801217-A223CB54-94B9-438F-9B26-C7941D8A1EA1Q33900032-38C4654B-D616-432B-BF1B-445EBD3BB675Q34107040-AB603D44-77DC-4020-A286-B359D7CA6AE2Q34343454-6907A64E-0018-4754-8D9B-F80CF31099E6Q34512492-46E9F6D9-8028-41B6-BB79-E582D2589E89Q34595772-9AD6A6E5-D977-4BA5-9718-14E3D7879452Q34739913-5D73F3F9-7D8E-4610-A920-55C0689012BFQ34801950-8E0E9918-6153-4B6E-ADAE-9F8E7F9376F3Q34991352-487EF247-37DE-4C9D-BC0E-0194F6C832FFQ35022739-5E74927E-8758-4780-92F6-9AC733FF2625Q35035686-B813BC5C-0F1B-4150-A0EF-4B627C189D34Q35058730-B1A0B339-51CB-4BD0-A8B5-AB2D91ECBB8FQ35115345-081A9A82-EBEC-4FDC-908B-69CE4F4B7339Q35239045-5140E29B-E08F-438F-A911-9A67019B8A97
P2860
Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Subtyping method for Escherich ...... ons to clinical manifestations
@ast
Subtyping method for Escherich ...... ons to clinical manifestations
@en
type
label
Subtyping method for Escherich ...... ons to clinical manifestations
@ast
Subtyping method for Escherich ...... ons to clinical manifestations
@en
prefLabel
Subtyping method for Escherich ...... ons to clinical manifestations
@ast
Subtyping method for Escherich ...... ons to clinical manifestations
@en
P2860
P356
P1476
Subtyping method for Escherich ...... ons to clinical manifestations
@en
P2093
Katharina E P Olsen
Søren Persson
P2860
P304
P356
10.1128/JCM.02591-06
P407
P577
2007-04-19T00:00:00Z